切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2021, Vol. 11 ›› Issue (05) : 301 -305. doi: 10.3877/cma.j.issn.2095-2007.2021.05.009

综述

泪液渗透压在干眼发生机制和临床应用中的研究进展
王静漪1, 接英2,()   
  1. 1. 100730 首都医科大学附属北京同仁医院2021级硕士研究生
    2. 100730 首都医科大学附属北京同仁医院 北京同仁眼科中心 北京市眼科研究所 北京市眼科学与视觉科学重点实验室
  • 收稿日期:2021-01-17 出版日期:2021-10-28
  • 通信作者: 接英
  • 基金资助:
    国家自然科学基金项目(81970764); 北京市自然科学基金项目(7182037)

Advances on the tear osmolarity of mechanism and clinical application in dry eye

Jingyi Wang1, Ying Jie2,()   

  1. 1. Master′s degree 2021, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
    2. Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100730, China
  • Received:2021-01-17 Published:2021-10-28
  • Corresponding author: Ying Jie
引用本文:

王静漪, 接英. 泪液渗透压在干眼发生机制和临床应用中的研究进展[J]. 中华眼科医学杂志(电子版), 2021, 11(05): 301-305.

Jingyi Wang, Ying Jie. Advances on the tear osmolarity of mechanism and clinical application in dry eye[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2021, 11(05): 301-305.

泪液渗透压升高是干眼发生与发展的核心机制,作为一项诊断和监测干眼的客观指标,泪液渗透压有重要的临床意义。有研究结果表明,泪液渗透压在干眼的发生机制中有重要作用,并在临床诊断与治疗中有广泛应用。本文中笔者就泪液渗透压在干眼发生机制和临床应用中的研究进展进行综述。

The increase of tear osmolarity is the core mechanism in the development of dry eye. As an objectively measurable indicator for the diagnosis and monitoring of dry eye, tear osmolarity has been widely used in clinic. It has been demonstrated that the tear osmolarity linked with dry eye, and has been used widely in clinical diagnosis and other aspects for dry eye. The research progress of tear osmolarity of mechanism and clinical application in dry eye were reviewed in this article.

表1 泪液渗透压与不同类型干眼间联系的文献汇总
表2 泪液渗透压的测量方法
[1]
亚洲干眼协会中国分会,海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组,中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识:检查和诊断(2020年)[J]. 中华眼科杂志202056(10):741-747.
[2]
接英,李思源. 重视干眼的规范化诊疗[J]. 眼科201928(6):401-403.
[3]
Nelson JD, Craig JP, Akpek EK, et al. TFOS DEWS Ⅱ introduction[J]. Ocular Surface, 2017, 15(3): 269-275.
[4]
Stahl U, Willcox M, Stapleton F. Osmolality and tear film dynamics[J]. Clinical & Experimental Optometry, 2012, 95(1): 3-11.
[5]
Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease[J]. Am J Ophthalmol, 2011, 151(5): 792-798.
[6]
Amparo F, Jin Y, Hamrah P, et al. What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease?[J]. Am J Ophthalmol, 2014, 157(1): 69-77.
[7]
Julio G, Lluch S, Pujol P, et al. Effects of tear hyperosmolarity on conjunctival cells in mild to moderate dry eye[J]. Ophthalmic Physiol Opt, 2012, 32(4): 317-323.
[8]
Galvez A, Morales MP, Eltit JM, et al. A rapid and strong apoptotic process is triggered by hyperosmotic stress in cultured rat cardiac myocytes[J]. Cell Tissue Res, 2001, 304(2): 279-285.
[9]
Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting[J]. Ocul Surf, 2013, 11(4): 246-258.
[10]
Lechner SG, Markworth S, Poole K, et al. The molecular and cellular identity of peripheral osmoreceptors[J]. Neuron, 2011, 69(2): 332-344.
[11]
Clouzeau C, Godefroy D, Riancho L, et al. Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro[J]. Mol Vis, 2012, 18: 851-863.
[12]
Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways[J]. Cornea, 2007, 26(4): 452-460.
[13]
Luo L, Li DQ, Corrales RM, et al. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface[J]. Eye Contact Lens, 2005, 31(5): 186-193.
[14]
Lam H, Bleiden L, Paiva CSD, et al. Tear cytokine profiles in dysfunctional tear syndrome[J]. Am J Ophthalmol, 2009, 147(2): 198-205.
[15]
Charles JD, Zeng W, Yi WC, et al. Tear interferon-gamma as a biomarker for evaporative dry eye disease[J]. Invest Ophth Vis Sci, 2016, 57(11): 4824-4830.
[16]
Kook KY, Jin R, Li L, et al. Tear osmolarity and matrix metallopeptidase-9 in dry eye associated with Sjgren′s syndrome[J]. Korean Journal of Ophthalmology, 2020, 34(3): 179-186.
[17]
Pflugfelder SC, Paiva CSD. The pathophysiology of dry eye disease: what we know and future directions for research[J]. Ophthalmology, 2017, 124(11): S4-S13.
[18]
Serdar A, Fatih T. Evaluation of tear osmolarity and tear function in patients with Behet′s syndrome[J]. Can J Ophthalmol, 2018, 54(2): 176-179.
[19]
Joossen C, Baán A, Moreno-Cinos C, et al. A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation[J]. Sci Rep, 2020, 10(1): 17268.
[20]
Mirinae K, Seung KH, Kyung-Sun N. Correlation between tear osmolarity and other ocular surface parameters in primary Sjgren′s syndrome[J]. Korean J Ophthalmol, 2017, 31(1): 25-31.
[21]
Ng ALK, Choy BNK, Chan TCY, et al. Comparison of tear osmolarity in rheumatoid arthritis patients with and without secondary Sjogren syndrome[J]. Cornea, 2017, 36(7): 805-809.
[22]
Miserocchi E, Iuliano L, Berchicci L, et al. Tear film osmolarity in ocular mucous membrane pemphigoid[J]. Cornea, 2014, 33(7): 668-672.
[23]
Türkylmaz K, Türkylmaz AK, Kurt A, et al. Investigation of tear osmolarity in early rheumatoid arthritis: relation to disease activity[J]. Can J Ophthalmol, 2013, 48(4): 235-239.
[24]
Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease[J]. Ophthalmology, 2017, 124(11): S20-S26.
[25]
Xiao JX, Muhammed YA, Chen X, et al. Functional and morphological evaluation of meibomian glands in the assessment of meibomian gland dysfunction subtype and severity[J]. Am J Ophthalmol, 2020, 209: 160-167.
[26]
Akpek EK, Wu HY, Karakus S, et al. Differential diagnosis of Sjgren versus non-Sjgren dry eye through tear film biomarkers[J]. Cornea, 2020, 39(8): 991-997.
[27]
洪晶. 密切关注眼表黏蛋白研究及其在干眼诊疗中的意义[J]. 中华实验眼科杂志202038(11):910-915.
[28]
Wylgaa A, Sdziak-Marcinek B, Pilch J, et al. Alteration of blinking and sex differences during physical exercise affect tear osmolarity[J]. J Hum Kinet, 2019, 67: 143-151.
[29]
Jie Y, Sella R, Feng J, et al. Evaluation of incomplete blinking as a measurement of dry eye disease[J]. The Ocular Surface, 2019, 17(3): 440-446.
[30]
Talens-Estarelles C, García-Marqués JV, Cervino A, et al. Use of digital displays and ocular surface alterations: A review[J]. The Ocular Surface, 2020, 19: 252-265.
[31]
Hu JW, Zhu XP, Pan SY, et al. Prevalence and risk factors of dry eye disease in young and middle-aged office employee: a Xi′an Study[J]. Int J Ophthalmol, 2021, 14(4): 567-573.
[32]
Yazici A, Sari ES, Sahin G, et al. Change in tear film characteristics in visual display terminal users[J]. Eur J Ophthalmol, 2015, 25(2): 85-89.
[33]
Montani G, Martino M. Tear film characteristics during wear of daily disposable contact lenses[J]. Clin Ophthalmol, 2020, 14: 1521-1531.
[34]
Ramamoorthy P, Khanal S, Nichols J. Inflammatory proteins associated with contact lens-related dry eye[J]. Cont Lens Anterior Eye, 2021: 101442.
[35]
Melhusseiny A, Akhalil A, Sheikh RH, et al. New approaches for diagnosis of dry eye disease[J]. Int J Ophthalmol, 2019, 12(10): 1618-1628.
[36]
Tomlinson A, Mccann LC, Pearce EI. Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques[J]. Cornea, 2010, 29(9): 1036-1041.
[37]
Pensyl CD, Benjamin WJ. Vapor pressure osmometry: minimum sample microvolumes[J]. Acta Ophthalmologica Scandinavica, 2009, 77(1): 27-30.
[38]
潘士印,肖湘华,王养正,等. 泪液渗透压与干眼[J]. 中华眼科杂志201147(5):475-477.
[39]
Fagehi R. Development in tear film osmolarity assessments: a review[J]. Nepal J Ophthalmol, 2021, 13(25): 122-132.
[40]
Cartes C, López D, Salinas D, et al. Dry eye is matched by increased intrasubject variability in tear osmolarity as confirmed by machine learning approach[J]. Archivos de la Sociedad Espaola de Oftalmología, 2019, 94(7): 337-342.
[41]
Park J, Choi Y, Han G, et al. Evaluation of tear osmolarity measured by I-Pen osmolarity system in patients with dry eye[J]. Sci Rep, 2021, 11(1): 7726.
[42]
Shimazaki J, Sakata M, Den S, et al. Tear film osmolarity measurement in Japanese dry eye patients using a handheld osmolarity system[J]. Diagnostics, 2020, 10(10): 789.
[43]
König S, Priglinger S, Schaumberger M, et al. Tear film osmolarity in normal individuals: comparison of two osmometers[J]. Klin Monbl Augenheilkd, 2020, 237(5): 649-654.
[44]
Alan T, Santosh K, Kanna R, et al. Tear film osmolarity: determination of a referent for dry eye diagnosis[J]. Invest Ophthalmol Vis Sci, 2006, 47(10): 4309.
[45]
Sullivan BD, Diane W, Nichols KK, et al. An objective approach to dry eye disease severity[J]. Invest Ophthalmol Vis, 2010, 51(12): 6125-6130.
[46]
Wang MTM, Ormonde SE, Muntz A, et al. Diagnostic profile of tear osmolarity and inter-ocular variability for dry eye disease[J]. Clin Exp Ophthalmol, 2020, 48(2): 255-257.
[47]
Sullivan BD. Variability of tear osmolarity measurements with a point-of-care system in healthy subjects-systematic review[J]. Cornea, 2019, 38(6): e21-e23.
[48]
Setten GBV. Osmokinetics: defining the characteristics of osmotic challenge to the ocular surface[J]. Klinische Monatsbltter für Augenheilkunde, 2020, 237(5): 644-648.
[49]
Tashbayev B, Utheim TP, Utheim YA, et al. Utility of tear osmolarity measurement in diagnosis of dry eye disease[J]. Sci Rep, 2020, 10(1): 5542.
[50]
Ozulken K, Aydemir GA, Tekin K, et al. Correlation of non-invasive tear break-up time with tear osmolarity and other invasive tear function tests[J]. Semin Ophthalmol, 2020, 35(1): 78-85.
[51]
Suzuki M, Massingale ML, Ye F, et al. Tear osmolarity as a biomarker for dry eye disease severity[J]. Invest Ophthalmol Vis Sci, 2010, 51(9): 4557-4561.
[52]
Utine CA, Bçakçgil M, Yavuz S, et al. Tear osmolarity measurements in dry eye related to primary Sjögren′s syndrome[J]. Curr Eye Res, 2011, 36(8): 683-690.
[53]
Pena-Verdeal H, García-Resúa C, Vazquez-Sanchez C, et al. Inter-eye osmolarity differences in patients with symptomatic and non-symptomatic dry eyes[J]. Arquivos Brasileiros de Oftalmologia, 2020, 83(2): 103-108.
[54]
Bunya VY, Fuerst NM, Pistilli M, et al. Variability of tear osmolarity in patients with dry eye[J]. JAMA Ophthalmol, 2015, 133(6): 662-667.
[1] 王胜男, 孙挥宇, 接英, 谢雯, 毛菲菲, 李丹, 鲁丹, 刘夕瑶. 慢性丙型肝炎患者干眼临床特征[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(01): 48-54.
[2] 孙艳华. 围绝经期干眼患者结膜上皮细胞中miR-146a、TRAF6的表达研究[J]. 中华细胞与干细胞杂志(电子版), 2021, 11(05): 279-283.
[3] 白静怡, 黄轩, 张益权, 田颖, 陶勇. 小鼠干眼模型构建及其角膜特征检测的实验研究[J]. 中华眼科医学杂志(电子版), 2023, 13(01): 12-17.
[4] 荆大兰, 江晓丹, 杨嘉瑞, 李学民. 眼表菌群改变与干眼关系的研究进展[J]. 中华眼科医学杂志(电子版), 2022, 12(06): 372-376.
[5] 程英, 安文在, 林丹婷, 王宁利. 肠道菌群与眼部常见疾病关系的研究进展[J]. 中华眼科医学杂志(电子版), 2022, 12(05): 305-309.
[6] 丁一, 郝然, 王嘉瑢, 李学民. 角膜神经改变与干眼的研究进展[J]. 中华眼科医学杂志(电子版), 2022, 12(04): 242-246.
[7] 姜雅琴, 刘丽峰, 刘秀花, 张亚丽. 白内障术后早期患者配戴绷带镜对泪膜质量及其动态变化影响的临床研究[J]. 中华眼科医学杂志(电子版), 2022, 12(04): 204-209.
[8] 赵鹏飞, 柳静, 徐雯, 胡雅斌, 翟长斌, 魏文斌. 术前应用人工泪液对FS-LASIK治疗高度近视眼术后干眼自觉症状和泪膜稳定性影响的临床研究[J]. 中华眼科医学杂志(电子版), 2020, 10(06): 326-332.
[9] 张薇, 李上, 董宏伟, 阮方, 李小娜, 接英. LipiView眼表面干涉仪辅助评估病毒性乙型肝炎患者干眼发生情况的临床研究[J]. 中华眼科医学杂志(电子版), 2020, 10(05): 275-280.
[10] 李妍, 陈佩卿, 陈子和, 徐佳, 陶永钢. 三种非甾体抗炎药物在超声乳化白内障吸除联合人工晶状体植入术围手术期的应用研究[J]. 中华眼科医学杂志(电子版), 2020, 10(02): 103-109.
[11] 李思源, 张鹏, 王滢珲, 接英. 重视围术期干眼的诊断、预防与治疗[J]. 中华眼科医学杂志(电子版), 2020, 10(02): 65-69.
[12] 于子桐, 杨嘉瑞, 李学民. 干眼对生活质量影响的相关研究进展[J]. 中华眼科医学杂志(电子版), 2020, 10(01): 51-57.
[13] 韦振宇, 刘含若, 梁庆丰. 我国干眼流行病学的研究进展[J]. 中华眼科医学杂志(电子版), 2020, 10(01): 46-50.
[14] 邰雪, 申颖, 赵海霞, 王召格, 关文英, 康欣. 儿童干眼症的病因及治疗进展[J]. 中华眼科医学杂志(电子版), 2019, 09(04): 252-256.
[15] 胡欢, 韩玲玲, 张明昌. 角膜上皮功能障碍的研究进展[J]. 中华眼科医学杂志(电子版), 2019, 09(02): 124-128.
阅读次数
全文


摘要